Table of Content

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by MAB Functionality
3.2. Snippet by MAB Structure
3.3. Snippet by Technology
3.4. Snippet by Application
3.5. Snippet by End-User
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing Prevalence of Chronic Diseases
4.1.2. Restraints
4.1.2.1. High Costs of Development and Treatment
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Reimbursement Analysis
5.6. Patent Analysis
5.7. SWOT Analysis
5.8. DMI Opinion
6. By MAB Functionality
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By MAB Functionality
6.1.2. Market Attractiveness Index, By MAB Functionality
6.2. Naked Monoclonal Antibodies*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Conjugated Monoclonal Antibodies
6.4. Bispecific Monoclonal Antibodies
7. By MAB Structure
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By MAB Structure
7.1.2. Market Attractiveness Index, By MAB Structure
7.2. Murine*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Chimeric
7.4. Humanized
7.5. Human
8. By Technology
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
8.1.2. Market Attractiveness Index, By Distribution Channel
8.2. Hybridoma technology*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Phage display
8.4. Single B-cell antibody technology
8.5. Recombinant antibody production
9. By Region
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
9.1.2. Market Attractiveness Index, By Region
9.2. North America
9.2.1. Introduction
9.2.2. Key Region-Specific Dynamics
9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By MAB Functionality
9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By MAB Structure
9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.2.8.1. The U.S.
9.2.8.2. Canada
9.2.8.3. Mexico
9.3. Europe
9.3.1. Introduction
9.3.2. Key Region-Specific Dynamics
9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By MAB Functionality
9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By MAB Structure
9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.3.8.1. Germany
9.3.8.2. UK
9.3.8.3. France
9.3.8.4. Italy
9.3.8.5. Spain
9.3.8.6. Rest of Europe
9.4. South America
9.4.1. Introduction
9.4.2. Key Region-Specific Dynamics
9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By MAB Functionality
9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By MAB Structure
9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.4.8.1. Brazil
9.4.8.2. Argentina
9.4.8.3. Rest of South America
9.5. Asia-Pacific
9.5.1. Introduction
9.5.2. Key Region-Specific Dynamics
9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By MAB Functionality
9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By MAB Structure
9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.5.8.1. China
9.5.8.2. India
9.5.8.3. Japan
9.5.8.4. South Korea
9.5.8.5. Rest of Asia-Pacific
9.6. Middle East and Africa
9.6.1. Introduction
9.6.2. Key Region-Specific Dynamics
9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By MAB Functionality
9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By MAB Structure
9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
9.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10. Competitive Landscape
10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis
11. Company Profiles
11.1. Amgen Inc.*
11.1.1. Company Overview
11.1.2. Product Portfolio and Description
11.1.3. Financial Overview
11.1.4. Key Developments
11.2. Biogen
11.3. Bristol-Myers Squibb Company
11.4. Eli Lilly and Company
11.5. F. Hoffmann-La Roche Ltd
11.6. GlaxoSmithKline plc
11.7. Novartis AG
11.8. Pfizer Inc.
11.9. Sanofi
11.10. Merck & Co., Inc.
LIST NOT EXHAUSTIVE
12. Appendix
12.1. About Us and Services
12.2. Contact Us